Shree Ram Proteins Board Meeting Outcome: Approves Q1 FY27 & FY26 Financials amidst Going Concern Uncertainty
Shree Ram Proteins Limited's Board Meeting on August 17, 2026, approved unaudited Q1 FY27 results and audited FY26 results. The company faces severe financial distress, with defaults on loans and statutory dues. Auditors issued an adverse opinion due to going concern uncertainties, noting auction of plant and machinery and failure to meet OTS installments.
The adverse audit opinion, material uncertainty regarding going concern, defaults on loans, and auction of assets indicate a high impact on the company's financial health and operational stability.
The company is facing significant financial distress, including defaults on loans and statutory dues, leading to an adverse audit opinion and concerns about its ability to continue as a going concern. The auction of its assets further highlights the severity of the situation.
Shree Ram Proteins Limited announced the outcome of its Board Meeting held on August 17, 2026. The Board considered, approved, and adopted the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report from the statutory auditors.
Furthermore, the Board considered, approved, and adopted the audited financial results for the quarter and year ended March 31, 2026, along with the audit report. These results and reports are enclosed with the outcome. The company also informed that its operations fall under a single segment, "Solvent Products," making segment reporting not applicable.
The company's financial statements highlight significant concerns regarding its going concern status. Notably, Shree Ram Proteins has defaulted on loan repayments and statutory dues. Despite accepting a one-time settlement (OTS) with Union Bank of India, the company failed to meet subsequent installment deadlines. The company is currently facing a shortage of working capital and has had its plant and machinery auctioned by the bank due to loan defaults. The auditors have expressed an adverse opinion due to material uncertainties, including the company's ability to continue as a going concern, and have pointed out several discrepancies in financial reporting and asset verification.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.